Insulin Delivery Devices Market Is Anticipated To Reach $19.8 Billion By 2025: Grand View Research, Inc.

 

The insulin delivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.

insulin-delivery-devices-market-by-product
Insulin delivery devices market, by product, 2014 – 2025 (USD Million)

Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.

Browse full research report on Insulin Delivery Devices Market: www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market     

Further key findings from the study suggest:                     

  • The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector’s highest share in this market.
  • Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.
  • North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth.
  • The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.
  • Some key players serving this vertical include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton, Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                            

Grand View Research has segmented the insulin delivery devices market on the basis of product, end-use, and region:

Insulin Delivery Devices Market Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Insulin syringes
  • Insulin pens
  • Insulin pumps
  • Insulin injectors

Insulin Delivery Devices End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Home care
  • Others

Insulin Delivery Devices Market Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  •  Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-insulin-delivery-devices-market-analysis                                                                                                                              

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Advertisements

Endocrine Testing Market Expanding at CAGR of 8.0% from 2013 to 2024

The global endocrine testing market is expected to reach USD 13.02 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population and growing rate of diseases such as obesity and diabetes is expected to drive the market growth.

The presence of a large population over 60 years, having lower immunity levels and are prone to neurological diseases, cardiac problems, cancers, and spinal injuries, is a high impact-rendering driver for the growth of endocrine testing market over the forecast period.

us-endocrine-testing-market.png

Sedentary lifestyles of people with unhealthy food habits and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is anticipated to contribute to industry growth substantially.

Technological advancements in terms of accuracy and affordability resulted in an increased usage of these tests. For instance, the influx of test kits, for home-based testing has fostered the demand for these techniques, helping the market to grow. Advancement in technology ensures diagnosis in less time and faster initiation of treatment.

Software have been designed to manage the workflow in the laboratories. Newer mobile apps have been introduced wherein a patient can be reminded about his appointment or test, and he will be able to contact physician whenever he wants. These advancements in technology is anticipated to propel the market growth over the forecast period.

Browse full research report on Endocrine Testing Market: www.grandviewresearch.com/industry-analysis/endocrine-testing-market

Further key findings from the study suggest:

  • The global thyroid stimulating hormone testing market is anticipated to reach 3.6 billion by 2024, at a CAGR of 10.2% from 2016 to 2024
  • In terms of test type, insulin test is expected to show the fastest growth over the forecast period
  • In terms of technology, Tandem Mass Spectrometry (TMS) held the largest share in 2016 and is expected to dominate the market during the forecast period
  • In terms of technology, sensor technology is expected to show the fastest growth during the forecast period
  • North America is expected to dominate the market followed by Europe and Asia Pacific region
  • Asia Pacific is projected to drive the market growth and provide numerous opportunities to industry players. Key factors attributed to market growth include growing R&D expenditure by the government and private agencies in order to improve diagnostic and therapeutic areas in the region
  • Some of the key companies present in the market include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                            

Grand View Research has segmented the global endocrine testing market report on the basis of test type, technology, end use, and region:

Test Type Outlook (Revenue, USD Million, 2013 – 2024)

  • Estradiol
  • FSH
  • hCG
  • LH
  • DHEAS
  • Progesterone
  • Testosterone
  • TSH
  • Prolactin
  • Cortisol
  • Insulin
  • Others

Technology Outlook (Revenue, USD Million, 2013 – 2024)

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal & Polyclonal antibody technologies
  • Sensor technology
  • Clinical chemistry
  • Others

End Use Outlook (Revenue, USD Million, 2013 – 2024)

  • Hospital
  • Commercial Laboratory
  • Ambulatory Care Centers
  • Others

Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-endocrine-testing-market                                                                                                                          

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Radiology Information System Market Is Getting Traction Due To Increase In Computing & Web-Based Solutions..!!

 

The global radiology information system market is expected to reach USD 980.2 million by 2024, according to a new report by Grand View Research, Inc. Rising demand for information technology solutions to streamline workflow in radiology units is contributing to the growth of RIS market. RIS allows radiologists and medical imaging professionals to keep a track of patient history and digital data generated during diagnosis and treatment procedures.

us-radiology-information-system-market

Computerized medical imaging provides interactive documents that are secured and convenient. These documents can be accessed across various healthcare departments. RIS provides a communication link between primary physicians and imaging departments for better care coordination, which can be beneficial for timely diagnosis or treatments to the patients.

The healthcare providers using certified RIS software are eligible to receive financial incentives. The care providers need to demonstrate stage 2 meaningful use of RIS software. Eligible professionals receive upwards of USD 63,750 from Medicaid and upwards of USD 44,000 from Medicare. This government initiative is a major contributor to the increased adoption of RIS software by the radiologists and medical imaging professionals.

Browse full research report on Radiology Information System Market: www.grandviewresearch.com/industry-analysis/radiology-information-system-ris-market                   

Further key findings from the report suggest:

  • The rapid growth in chronic diseases along with rising geriatric population base is accountable for RIS market growth.
  • The available types of radiology information solutions include integrated and standalone systems. Of these, the integrated RIS accounted for majority of the segment share in the year 2015.
  • Integrated RIS offers data analysis with the help of picture archiving and communication system (PACS) for development of IT service models
  • The RIS deployment modes include web-based systems, cloud-based systems, and on premise systems. Of these, web-based systems held majority of the market share in 2015, due to offered workflow enhancement features such as scheduling, document imaging, automated insurance eligibility functions and billing.
  • Hospitals, emergency healthcare service providers, and physicians comprise of RIS end-users. Hospitals majorly prefer radiology solutions for patient scheduling, appointments, and for tracking patient history and records.
  • North America dominated the market in 2015 in terms of revenue share pertaining to the technological advancements and presence of major market players in the region.
  • The American College of Radiology has collaborated with GE Healthcare to bring the first leading boot camp training for breast cancer in Saudi Arabia and the Middle East to enter and expand in the region.
  • GE Healthcare, Siemens AG, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Epic Systems, McKesson Corporation, Philips Healthcare, Merge Healthcare, Inc., and MedInformatix, Inc. are some of the key players operating in this market.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                           

Grand View Research has segmented the radiology information system market based on product, deployment mode, end-use, and region:

Product Outlook (Revenue, USD Million; 2014 – 2024)

  • Integrated
  • Standalone

Deployment Mode Outlook (Revenue, USD Million; 2014 – 2024)

  • Cloud-based
  • Web-based
  • On-premise

End-Use Outlook (Revenue, USD Million; 2014 – 2024)

  • Hospitals
  • Outpatient Department (OPD) Clinics
  • Others

Regional Outlook (Revenue, USD Million; 2014 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    •  UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • SouthAfrica

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-radiology-information-system-ris-market                                                                                                                       

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Therapeutic Respiratory Devices Market Is Increasing Due To Rising Prevalence Of Respiratory Diseases Till 2025

 

The global therapeutic respiratory devices market is anticipated to reach USD 18.0 billion by 2025, according to a new report by Grand View Research, Inc. Growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements are the key factors that are driving the market growth.

The therapeutic respiratory devices market growth is anticipated to increase due to rapid technological advancements in the market.Now-a-days, the respiratory monitoring devices utilize software applications for the collection and analysis of data from ventilators equipped across the health system. The tools in the software application allow improvised patient monitoring by the measurement of parameters such as process and clinical variation in the ventilator therapy.

us-therapeutic-respiratory-devices-market.png

Furthermore, waveform capnography is a useful technical advancement in monitoring the carbon dioxide levels. The launch of new products such as automated and stand-alone pressure controller for mechanical ventilators boost the growth of therapeutic respiratory devices market. These pressure controllers enable reduction in the risk of tracheal injuries and Ventilator Associated Pneumonia (VAP). For instance, in May 2015, Fischer and Paykel launched its new product AIRVO Nasal High Flow System, which provides comfort and stability for patients. It has soft contoured cheek pads and prongs, uninterrupted power supply transport, and tube technology with two way spiral design. The company also offers humidifier with integrated flow generator, which delivers high flows of air mixture to spontaneously breathing patient. Such factors are bolstering the growth of the market.

Browse full research report on Therapeutic Respiratory Devices Market: www.grandviewresearch.com/industry-analysis/therapeutic-respiratory-devices-market               

Further key findings from the study suggest:

  • Positive airway pressure devices accounted for the largest share in 2016 owing to technological innovations resulting in increased portability and shelf life.
  • HEPA filter technology accounted for the largest share in 2016, due to the prevalence of respiratory diseases & their transmission coupled with technological advancements in this segment.
  • Humidifiers is anticipated to be the fastest growing segment in the forecast period owing to the rising demand for humidifiers in hospitals, schools, home, & healthcare entities, and increased prevalence of airborne infections such as tuberculosis.
  • North America therapeutic respiratory devices market is the largest market and is expected to maintain its position over the forecast period owing to the presence of large geriatric population base and rising prevalence of chronic respiratory diseases.
  • Major players of the market include, Carefusion Corporation, GE Heathcare, AirSep Corporation, Philips Healthcare, Smiths Medical and Covidien PLC.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                          

Grand View Research has segmented the global therapeutic respiratory devices market on the basis of product, technology, filters, and region:

Therapeutic Respiratory Devices Product Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Nebulizers
    • Compressor-based nebulizers
    • Piston based hand held nebulizer
    • Ultrasonic Nebulizer
  • Humidifiers
    • Heated humidifiers
    • Passover humidifiers
    • Integrated humidifiers
    • Built-In humidifiers
    • Stand-alone humidifiers
  • Oxygen Concentrators
    • Fixed oxygen concentrators
    • Portable oxygen concentrators
  • Positive Airway Pressure Devices
    • Continuous positive airway pressure devices
    • Auto-titrating positive airway pressure devices
    • Bi-level positive airway pressure devices
  • Ventilators
    • Adult ventilators
    • Neonatal ventilators
  • Capnographs
  • Gas Analyzers

Therapeutic Respiratory Devices Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Electrostatic Filtration
  • HEPA filter technology
  • Hollow fiber filtration
  • Microsphere separation

Therapeutic Respiratory Devices Filters Outlook (Revenue, USD Million, 2014 – 2025)

  • Nebulizer filters
    • Inlet filter
    • Replacement filter
    • Cabinet filter
  • Humidifier filters
    • Wick filters
    • Permanent cleanable filters
    • Mineral absorption pads
    • Demineralization cartridges
  • Positive airway pressure devices filter
    • Ultra fine foam inlet filters
    • Polyester non-woven fiber filters
    • Acrylic & Polypropylene fiber filters
  • Oxygen concentrator filters
    • HEPA filter
    • Cabinet filter
    • Pre-Inlet filter
    • Inlet filter
    • Micro disk filter
    • Felt intake filter
    • Bacterial filter
    • Hollow-membrane filter
  • Ventilator filters
    • Mechanical filters
      • HEPA Filters
      • ULPA Filters
      • Activated carbon filters
    • Electrostatic filters
      • Tribocharged filters
      • Fibrillated filters

Therapeutic Respiratory Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Spain
    • Germany
    • France
    • Italy
    • Switzerland
  • Asia Pacific
    • India
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-therapeutic-respiratory-devices-market                                                                                                                     

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Biosensors Market Expanding at CAGR of 7.9% CAGR from 2012 to 2020

The global biosensors market is anticipated to reach USD 21.2 billion by 2020, according to a new report by Grand View Research, Inc. Myriad applications in the medical field, rising diabetic population base, high demand for miniature diagnostic devices, and rapid technological advancements are the key factors that are driving the market growth.

Growing technological developments within all the segments of biosensors are expected to be significant drivers for the growth of biosensors market over the forecast period. For instance, novel advancement in the development of optical quantum dots is expected to provide novel avenues for application in biopharmaceutical development, proteomic analysis, and vaccine development. Similarly, growing applications for thermal biosensors in biomolecular interaction and hybridization analysis, environmental monitoring, and cosmetic analysis are expected to provide the market with greater application opportunities resulting in increased market demand. The development of nano particle based electrochemical biosensors and nanotechnology-based usage contribute to increased importance of this driver over the forecast period.

us-biosensors-market.png

Moreover, growing worldwide prevalence of diabetes (both type I and type II) is expected to drive market expansion over the forecast period. According to the estimates of the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 425 million in 2017 to 629 million in 2045.

Browse full research report on Biosensors Market: www.grandviewresearch.com/industry-analysis/biosensors-market     

Further Key findings from the study suggest:

  • Medical application segment dominated the market share in 2013. It is considered an essential tool in the detection and monitoring of a wide range of medical conditions from diabetes to cancer.
  • Electrochemical biosensors accounted for the largest market share in 2013 because of widespread applications for quantification and analysis in biochemical and biological processes.
  • Biosensors in food industry are expected to witness fastest growth over the forecast period owing to the rising pressure from regulatory bodies pertaining to the hygiene standards of the food items where biosensors play a vital role for detecting pathogens, allergens, and pesticides in the food items.
  • Asia Pacific biosensors market is expected to grow with the highest CAGR over the forecast period owing to presence of high unmet medical needs pertaining to target disease segments, growing patient awareness levels, and constantly improving healthcare expenditure in the region.
  • Major players of the market include, AZUR Environmental, Abbott Laboratories, Biosensor BV, Bayer AG, Cranfield Biotechnology Centre, DuPont Biosensor Materials, Ercon, Inc., and Johnson & Johnson.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                          

Grand View Research has segmented the global biosensors market on the basis of application, technology, end user and region:

Biosensors Technology Type Outlook (Revenue, USD Million, 2014 – 2020)

  • Thermal
  • Electrochemical
  • Piezoeletric
  • Optical

Biosensors Application Outlook (Revenue, USD Million, 2014 – 2020)

  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood gas analyzer
    • Preganancy testing
    • Drug discovery
    • Infectious disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others

Biosensors End User Outlook (Revenue, USD Million, 2012 – 2020)

  • Home healthcare diagnostics
  • PoC testing
  • Food industry
  • Research Laboratories
  • Security and Bio-defense

Biosensors Regional Outlook (Revenue, USD Million, 2012 – 2020)

  • North America
  • Europe
  • Asia Pacific
  • RoW

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-biosensors-market                                                                                                           

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Protein Labeling Market Driven By Rising Awareness For Cardiac Conditions Till 2025: Grand View Research, Inc.

 

The global defibrillator market is expected to reach USD 18.8 billion by 2025, according to a new report by Grand View Research, Inc. To increase the availability of defibrillators in developed countries, the government is making amendments in their policies to make the product available at various places.

Training programs and awareness campaigns are conducted at regular intervals, which are increasing awareness about defibrillation and indirectly increasing the demand for home care products as well as public access defibrillators.

The healthcare expenditure at a global level is rising, along with increasing penetration of public and private health insurance. This rise is expected to fuel demand for defibrillators across various end-user segments.

us-defibrillator-market.png

Defibrillator market is driven by innovative processes. For instance, a program under trial in Sweden is likely to deliver AEDs via drones. This is anticipated to reduce the delivery time for defibrillators, thus saving more lives. The growth of this industry can be attributed to new product development, mergers & acquisitions, and rising market penetration.

Browse full research report on Defibrillators Market: www.grandviewresearch.com/industry-analysis/defibrillators-market

Further Key findings from the study suggest:

  • Implantable Convertible Defibrillator (ICD) was the major contributor in the defibrillator industry in 2016
  • External defibrillators recorded the fastest growth in the industry
  • Hospitals were the major contributors in the end-use segment in 2016
  • The public access market was the fastest growing end-user segment of the overall defibrillator industry in 2016
  • North America held a major market share of the defibrillator industry
  • Asia Pacific region is anticipated to exhibit fastest growth in the global defibrillator industry
  • Some of the key players are Medtronic; St. Jude Medical LLC; Boston Scientific Corporation; LivaNova; Koninklijke Philips N.V.; ZOLL Medical Corporation; Cardiac Science; Physio-Control Inc.; Nihon Kohden Corporation; Defibtech LLC; HeartSine Technologies LLC; Progetti Srl; Fukuda Denshi Co., Ltd.; and Schiller AG
  • New product development, mergers & acquisitions, and regional expansion are some of the strategic initiatives undertaken by the key players

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the defibrillator market report by product, end-use, and region:

Defibrillator Product Outlook (Revenue, USD Million; 2014–2025)

  • Implantable Cardioverter Defibrillator
  • S-ICD
  • T-ICD
  • CRT-D
  • Single Chamber
  • Dual Chamber
  • External Defibrillator (ED)
  • Manual ED
  • Automated ED
  • Wearable Cardioverter Defibrillator

Defibrillator End-use Outlook (Revenue, USD Million; 2014–2025)

  • Hospital
  • Prehospital
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare

Defibrillator Regional Outlook (Revenue, USD Million; 2014–2025)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Mexico
  • Brazil
  • MEA
  • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-defibrillators-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Western Blotting Market Is Increasing Due To Growing Prevalence Of HIV/AIDS & Lyme Disease Till 2025

 

The global western blotting market is anticipated to reach a value of USD 958.4 millionby 2025, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of western blotting market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

us-western-blotting-market.png
U.S. western blotting market, by product, 2014 – 2025 (USD Million)

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Browse full research report on Western Blotting Market: www.grandviewresearch.com/industry-analysis/western-blotting-market     

Further Key findings from the study suggest:

  • In 2016, consumables segment held the largest market share and is also expected to exhibit fastest growth over the forecast period owing to rising diagnostic and research-based activities requiring western blotting
  • Amongst the application segment, biomedical & biochemical research contributed towards the largest revenue share in 2016 due to increasing government spending in proteomics research
  • The disease diagnostics segment is anticipated to witness highest CAGR over the forecast period due to rising epidemiology of HIV, Lyme, and other related diseases
  • Amongst the end-use segment, such as academic & research institutes dominated the market in 2016 owing to growing number of research activities conducted by educational institutions supported by government funding
  • The pharmaceutical and biotechnology companies are expected to grow at a significant CAGR over the forecast period due to increasing R&D spending by such companies
  • Some of the key players are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Bio-Techne Corporation, PerkinElmer, Inc., and Merck KGaA.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices                                                                                                                                              

Grand View Research has segmented the western blotting market on the basis of product, application, end-use and region:

Western Blotting Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Instruments
    • Gel Electrophoresis Instruments
    • Blotting Systems
      • Semi-Dry Blotting Instruments
      • Wet Blotting Instruments
    • Imagers
      • Chemiluminescent Imagers
      • Fluorescent Imagers
      • Others
  • Consumables
    • Reagents
    • Kits
    • Others

Western Blotting Application Outlook (Revenue, USD Million; 2014 – 2025)

  • Biomedical & Biochemical Research
  • Disease Diagnostics
  • Agriculture
  • Others

Western Blotting End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Centers
  • Others

Western Blotting Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-western-blotting-market                                                                                                          

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com